Human leukocyte antigen G single-nucleotide polymorphism -201 (CC-CC) donor-recipient genotype matching as a predictor of severe cardiac allograft vasculopathy.

[1]  M. Reynaud‐Gaubert,et al.  HLA‐G*01:04∼UTR3 Recipient Correlates With Lower Survival and Higher Frequency of Chronic Rejection After Lung Transplantation , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2]  N. Rouas-Freiss,et al.  HLA-G: An Immune Checkpoint Molecule. , 2015, Advances in immunology.

[3]  Josef Stehlik,et al.  The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  S. Prakash,et al.  HLA-G gene expression influenced at allelic level in association with end stage renal disease and acute allograft rejection. , 2014, Human immunology.

[5]  P. Horn,et al.  HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy , 2014, Journal of Immunological Research.

[6]  Juan Wu,et al.  HLA-G Dimers in the Prolongation of Kidney Allograft Survival , 2014, Journal of immunology research.

[7]  E. Donadi,et al.  Transcriptional and Posttranscriptional Regulations of the HLA-G Gene , 2014, Journal of immunology research.

[8]  O. Doumbo,et al.  HLA-G UTR Haplotype Conservation in the Malian Population: Association with Soluble HLA-G , 2013, PloS one.

[9]  V. Rao,et al.  Human Leukocyte Antigen-G Inhibits Neutrophil Adhesion to Coronary Artery Endothelial Cells Injured by Tumor Necrosis Factor Alpha , 2013 .

[10]  V. Rao,et al.  Human Leukocyte Antigen-G Inhibits Human Coronary Artery Smooth Muscle Cell Proliferation , 2013 .

[11]  A. Minguela,et al.  Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy. , 2013, Human immunology.

[12]  M. Cortey,et al.  HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression. , 2013, Human immunology.

[13]  V. Rao,et al.  The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  J. Peña,et al.  14-Base pair polymorphism of human leukocyte antigen-G as genetic determinant in heart transplantation and cyclosporine therapy monitoring. , 2009, Human immunology.

[16]  P. Moreau,et al.  Non-classical transcriptional regulation of HLA-G: an update , 2009, Journal of cellular and molecular medicine.

[17]  N. Rouas-Freiss,et al.  Immunohistochemical Study of HLA‐G Expression in Lung Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  M. Bicalho,et al.  A study of HLA-G polymorphism and linkage disequilibrium in renal transplant patients and their donors. , 2009, Transplant immunology.

[19]  V. Rao,et al.  Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[20]  V. Rao,et al.  Cardiac allograft vasculopathy: a review. , 2005, Canadian journal of surgery. Journal canadien de chirurgie.

[21]  J. Dausset,et al.  Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation. , 2003, Journal of hepatology.

[22]  D. Krebs,et al.  Association of soluble HLA-G plasma levels with HLA-G alleles. , 2001, Tissue antigens.

[23]  N. Morling,et al.  Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. , 1998, Human immunology.

[24]  J. Towbin,et al.  Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. Pediatric Heart Transplant Study Group. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  Malcolm E. Turner,et al.  The Decomposition of Time-Varying Hazard into Phases, Each Incorporating a Separate Stream of Concomitant Information , 1986 .